4//SEC Filing
Caladrius Biosciences, Inc. 4
Accession 0001144204-16-109548
$LSTACIK 0000320017operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:51 PM ET
Size
9.9 KB
Accession
0001144204-16-109548
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Common Stock
2016-06-22+7,500→ 319,431 total - Award
Options to Purchase Common Stock
2016-06-22+12,500→ 12,500 totalExercise: $0.52From: 2017-06-22Exp: 2026-06-22→ Common Stock (12,500 underlying)
Holdings
- 19,531(indirect: By Trust)
Common Stock
- 84,331(indirect: By IRA)
Common Stock
- 8,012(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents 7,500 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017.
- [F2]Includes 9,000 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 25, 2017 and 7,500 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017.
Documents
Issuer
Caladrius Biosciences, Inc.
CIK 0000320017
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000320017
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:51 PM ET
- Size
- 9.9 KB